SG Americas Securities’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-875
Closed -$41K 3700
2018
Q4
$41K Buy
+875
New +$101K ﹤0.01% 2846
2018
Q3
Sell
-81
Closed -$15K 3533
2018
Q2
$15K Sell
81
-34
-30% -$7.93K ﹤0.01% 3255
2018
Q1
$29K Buy
115
+1
+0.9% +$274 ﹤0.01% 3132
2017
Q4
$33K Buy
+114
New +$32.6K ﹤0.01% 3022
2016
Q2
Sell
-246
Closed -$66K 3080
2016
Q1
$66K Buy
+246
New +$65.7K ﹤0.01% 2722
2014
Q4
Sell
-220
Closed -$69K 3428
2014
Q3
$69K Buy
220
+89
+68% +$32K ﹤0.01% 2442
2014
Q2
$52K Sell
131
-358
-73% -$148K ﹤0.01% 2402
2014
Q1
$271K Buy
+489
New +$335K ﹤0.01% 1800

Other funds holding ACGN

SG Americas Securities's ACGN Position: Q1 2019 in Review

SG Americas Securities sold out of Aceragen Inc (ACGN) in Q1 2019, closing a stake of 875 shares — an estimated $41K sold.

SG Americas Securities first reported a position in ACGN in Q1 2014 and held it in 8 quarters. The position peaked at $271K in Q1 2014. 69 funds tracked by Wall St. Rank hold ACGN as of Q1 2019.

  • SG Americas Securities reported no remaining Aceragen Inc position as of Q1 2019 after selling out during the quarter.
  • SG Americas Securities sold 875 Aceragen Inc shares in Q1 2019, an estimated $41K.
  • SG Americas Securities first reported a position in Aceragen Inc in Q1 2014 and held it in 8 quarters.
  • SG Americas Securities's Aceragen Inc position peaked at $271K in Q1 2014.
  • 69 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2019.

Based on SG Americas Securities's 13F filing for Q1 2019, filed 29 Apr 2019.